Simon N.R. Harford Amicus Therapeutics, Inc. (FOLD) insider trading activity

Simon N.R. Harford is Chief Financial Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 143,595 shares of FOLD, which is worth approximately $1.36 Million. The most recent transaction as insider was on Dec 26, 2025, when has been sold 71,303 shares (Common Stock) at a price of $14.25 per share, resulting in proceeds of $1,016,067. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 144K

33.18% 3M change

36.86% 12M change

Total Value Held $1.36 Million

Simon N.R. Harford Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2025	SELL Payment of exercise price or tax liability	$1,016,067 $14.25 p/Share	71,303 Reduced 33.18%	143,595 Common Stock
Aug 21 2025	SELL Payment of exercise price or tax liability	$95,220 $7.6 p/Share	12,529 Reduced 5.51%	214,898 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	83,073 Added 26.75%	227,427 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$69,657 $9.31 p/Share	7,482 Reduced 4.93%	144,354 Common Stock
Aug 21 2024	SELL Payment of exercise price or tax liability	$151,475 $12.09 p/Share	12,529 Reduced 7.62%	151,836 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	57,392 Added 25.88%	164,365 Common Stock
Aug 21 2023	BUY Grant, award, or other acquisition	-	106,973 Added 50.0%	106,973 Common Stock

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

CFO and Treasurer

SNH

Simon N.R. Harford

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account